2/20
08:03 am
lmat
LeMaitre Vascular (NASDAQ:LMAT) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $95.00 price target on the stock.
Low
Report
LeMaitre Vascular (NASDAQ:LMAT) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $95.00 price target on the stock.
2/20
07:51 am
lmat
Rating for LMAT
Low
Report
Rating for LMAT